These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 15329423)

  • 1. Cardiac replacement with a total artificial heart as a bridge to transplantation.
    Copeland JG; Smith RG; Arabia FA; Nolan PE; Sethi GK; Tsau PH; McClellan D; Slepian MJ;
    N Engl J Med; 2004 Aug; 351(9):859-67. PubMed ID: 15329423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factor analysis for bridge to transplantation with the CardioWest total artificial heart.
    Copeland JG; Smith RG; Bose RK; Tsau PH; Nolan PE; Slepian MJ
    Ann Thorac Surg; 2008 May; 85(5):1639-44. PubMed ID: 18442554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CardioWest (Jarvik) total artificial heart: a single-center experience with 42 patients.
    Roussel JC; Sénage T; Baron O; Périgaud C; Habash O; Rigal JC; Treilhaud M; Trochu JN; Despins P; Duveau D
    Ann Thorac Surg; 2009 Jan; 87(1):124-9; discussion 130. PubMed ID: 19101284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total artificial heart bridge to transplantation: a 9-year experience with 62 patients.
    Copeland JG; Smith RG; Arabia FA; Nolan PE; McClellan D; Tsau PH; Sethi GK; Bose RK; Banchy ME; Covington DL; Slepian MJ
    J Heart Lung Transplant; 2004 Jul; 23(7):823-31. PubMed ID: 15261176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of a left ventricular assist device for end-stage heart failure.
    Rose EA; Gelijns AC; Moskowitz AJ; Heitjan DF; Stevenson LW; Dembitsky W; Long JW; Ascheim DD; Tierney AR; Levitan RG; Watson JT; Meier P; Ronan NS; Shapiro PA; Lazar RM; Miller LW; Gupta L; Frazier OH; Desvigne-Nickens P; Oz MC; Poirier VL;
    N Engl J Med; 2001 Nov; 345(20):1435-43. PubMed ID: 11794191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
    Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International experience with the CardioWest total artificial heart as a bridge to heart transplantation.
    Arabia FA; Copeland JG; Smith RG; Sethi GK; Arzouman DA; Pavie A; Duveau D; Keon WJ; Masters R; Foy B; Carrier M; Dembitsky W; Long J; Kormos R
    Eur J Cardiothorac Surg; 1997 Apr; 11 Suppl():S5-10. PubMed ID: 9271174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
    Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
    J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal timing of cardiac transplantation after ventricular assist device implantation.
    Gammie JS; Edwards LB; Griffith BP; Pierson RN; Tsao L
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1789-99. PubMed ID: 15173738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with more than 100 total artificial heart implants.
    Copeland JG; Copeland H; Gustafson M; Mineburg N; Covington D; Smith RG; Friedman M
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):727-34. PubMed ID: 22245242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CardioWest temporary total artificial heart.
    Platis A; Larson DF
    Perfusion; 2009 Sep; 24(5):341-6. PubMed ID: 19917572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.
    McCarthy PM; Portner PM; Tobler HG; Starnes VA; Ramasamy N; Oyer PE
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):578-86; discussion 586-7. PubMed ID: 1921434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bridge to transplantation with the CardioWest total artificial heart: the international experience 1993 to 1995.
    Copeland JG; Pavie A; Duveau D; Keon WJ; Masters R; Pifarre R; Smith RG; Arabia FA
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):94-9. PubMed ID: 8820088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
    Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure.
    Frigerio M; Gronda EG; Mangiavacchi M; Andreuzzi B; Colombo T; De Vita C; Oliva F; Quaini E; Pellegrini A
    J Heart Lung Transplant; 1997 Feb; 16(2):160-8. PubMed ID: 9059927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study.
    Holman WL; Kormos RL; Naftel DC; Miller MA; Pagani FD; Blume E; Cleeton T; Koenig SC; Edwards L; Kirklin JK
    J Heart Lung Transplant; 2009 Jan; 28(1):44-50. PubMed ID: 19134530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.